Mirena levonorgestrel-releasing intrauterine system now approved for 6 years of pregnancy prevention
Updates from the Exchange
Wondering What’s New In Contraceptive R&D Investments & Resources? Check out the event recording!
Society of Family Planning Annual Meeting features several contraceptive R&D presentations
2020 G-FINDER Report breaks down the latest data on R&D investments in sexual & reproductive health
Special issue of Biology of Reproduction highlights contraceptive development
Caya Diaphragm: How a New Self-Care Product in Niger Is Meeting Women’s Unique Needs During COVID-19
Submit your nominations for the 2020 Innovating for Impact Awards by July 31!
SSR offering free trial membership - join peers in reproduction research!
Get a 360° view of male contraception with MCI’s new podcast, Intended
Help shape the future of contraceptives
The FDA Approves the First Non-Hormonal Prescription Birth Control Gel, Phexxi™
Exciting Opportunities from The Male Contraceptive Initiative